OmniaBio Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Financing Rounds
  • 1

  • Investments
  • 1

OmniaBio General Information

Description

Operator of a contract development and manufacturing organization intended to catalyze the development of pioneering medicine in areas of unmet medical needs. The company is engaged in the development and manufacturing of gene-modified cell therapies and viral vectors, enabling pharmaceutical companies to develop medicines for the treatment of cancer, cardiovascular diseases, Parkinson's disease and diabetes.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 175 Longwood Road South
  • Hamilton, Ontario L8P 0A1
  • Canada
+1 (226)
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Biotechnology
Corporate Office
  • 175 Longwood Road South
  • Hamilton, Ontario L8P 0A1
  • Canada
+1 (226)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

OmniaBio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore OmniaBio‘s full profile, request access.

Request a free trial

OmniaBio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

OmniaBio Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore OmniaBio‘s full profile, request access.

Request a free trial

OmniaBio Investments (1)

OmniaBio’s most recent deal was a Joint Venture with LineaBio. The deal was made on 01-Jan-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
LineaBio 01-Jan-2023 Joint Venture Drug Discovery
To view OmniaBio’s complete investments history, request access »

OmniaBio FAQs

  • When was OmniaBio founded?

    OmniaBio was founded in 2022.

  • Where is OmniaBio headquartered?

    OmniaBio is headquartered in Hamilton, Canada.

  • What is the size of OmniaBio?

    OmniaBio has 200 total employees.

  • What industry is OmniaBio in?

    OmniaBio’s primary industry is Other Pharmaceuticals and Biotechnology.

  • Is OmniaBio a private or public company?

    OmniaBio is a Private company.

  • What is the current valuation of OmniaBio?

    The current valuation of OmniaBio is .

  • What is OmniaBio’s current revenue?

    The current revenue for OmniaBio is .

  • Who are OmniaBio’s investors?

    Centre for Commercialization of Regenerative Medicine and Medipost have invested in OmniaBio.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process